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Skin, as the outermost organ in the human body, continu-
ously confronts the external environment and serves as a pri-
mary defense system. The protective functions of skin include
UV-protection, anti-oxidant and antimicrobial functions. In
addition to these protections, skin also acts as a sensory organ
and the primary regulator of body temperature. Within these
important functions, the epidermal permeability barrier, which
controls the transcutaneous movement of water and other
electrolytes, is probably the most important. This permeability
barrier resides in the stratum corneum, a resilient layer com-
posed of corneocytes and stratum corneum intercellular lipids.
Since the first realization of the structural and biochemical
diversities involved in the stratum corneum, a tremendous
amount of work has been performed to elucidate its roles and
functions in the skin, and in humans in general. The pertur-
bation of the epidermal permeability barrier, previously spec-
ulated to be just a symptom involved in skin diseases, is
currently considered to be a primary pathophysiologic factor
for many skin diseases. In addition, much of the evidence
provides support for the idea that various protective functions
in the skin are closely related or even co-regulated. In this
review, the recent achievements of skin researchers focusing
on the functions of the epidermal permeability barrier and their
importance in skin disease, such as atopic dermatitis and
psoriasis, are introduced.
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INTRODUCTION
The skin, as an interface between the organism
and the external environment, plays a major role
in protecting and supporting the life it encloses.
The functions of human skin include the main-
tenance of body temperature, recognition of the
outer environment, defense against microor-
ganisms and protection from harmful materials in
the external environment. Among these important
functions, defensive functions can be further clas-
sified as physical, thermal, immune, ultra- violet,
oxidant, racial, antimicrobial and the permea-
bility barrier.
The epidermis is the outermost viable layer of
the skin and expresses various proteins and other
molecules that perform the above mentioned
protective functions. Inflammatory mediators such
as prostaglandins, eicosanoids, leukotrienes, hista-
mines and cytokines are synthesized and secreted
from keratinocytes and regulate the skin's im-
mune responses.1 UV-absorbing molecules, in-
cluding melanin, trans-urocanic acid, vitamin D
and C metabolites, and heat-shock proteins are
also expressed in keratinocytes and play impor-
tant roles in thermal and UV-barrier functions.
2-5
The antimicrobial systems in skin are primarily
mediated through the surface lipids, skin surface
acidification, iron-binding proteins and antimi-
crobial peptides.
6,7
The permeability barrier func-
tion, which impedes the transcutaneous move-
ment of water and other important electrolytes, is
the most important defensive functions for ter-
restrial life.
The outermost layer of the skin, the stratum
corneum (SC), primarily mediates this permea-
bility barrier function (Fig. 1). SC is composed of
two different structural components: the corneo-
cytes and intercorneocyte lipids. Both components
are derived from keratinocytes through the ter-
minal differentiation process. Considerable efforts
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have been made to elucidate the structure, func-
tion and biochemistry of the SC and, about two
decades ago, Elias proposed the 'brick and mortar
model', in which the SC is composed of flat cells
(bricks) surrounded by a lipid matrix (mortar).8
Since then, many studies have been performed to
elucidate the role of the SC at the organismal, bio-
chemical and molecular biological levels. The
corneocytes, as terminal differentiation forms of
keratinocytes, provide structural supports for the
SC and act as hydrating reservoirs for adequate
enzymatic processes in the SC. The cornified en-
velope (CE), which encapsulates the corneocytes
in SC, is a 15-20 nm-thick structure comprising
defined structural proteins.9 A 5nm-thick structure
of specialized lipids, identified as the cornified
lipid envelope (CLE), encloses the CE and this
membrane-bound lipid monolayer provides hy-
drophobic interfaces between the hydrophilic
surface of the CE and the highly hydrophobic
lipid lamellae.10 Recently, a detailed elucidation of
the component proteins of the CE and its forma-
tion has been reported.
11
In addition to these major structural domains,
the corneodesmosome(CD), which corresponds to
desmosome in the epidermis, is another impor-
tant components in the SC. Generally, the inte-
grity of the SC is maintained by these intercellular
proteins which connect to adjacent corneocytes,
both in the plane of the SC layer and in adjacent
layers. In the SC, the CD structures represent the
primary cohesive force and they are directly
related the desquamation process. These struc-
tures are composed of certain proteins, including
desmocollin and desmoglein, and special protein-
degrading enzymes which are presented in the SC
and play a crucial role in the desquamation pro-
cess.12 Water activity and pH control the activity
of the protease in the SC. The cholesterol sulfate/
cholesterol ratio and protease inhibitors in the SC
are also important regulators of the protease
activity.13,14
In this review, we introduce recent achieve-
ments in the research of skin barrier functions and
their significances in treating atopic dermatitis
and psoriasis.
THE INTERRELATIONSHIPS OF DEFENSIVE
FUNCTIONS IN THE SKIN
In addition to the permeability barrier function,
the SC also plays an important role in other
critical functions such as antimicrobial defense,
the hydration of viable epidermis, UV defense,
antioxidant defense and the formation of a
mechanical barrier. Due to structural hetero-
geneity, either corneocytes or the SC intercellular
lipids mediate the defensive functions of the SC:
the extracellular lipids act as permeability, anti-
oxidant, and antimicrobial barriers, and the cor-
neocytes act as UV and mechanical barriers.
Recent reports, however, show that these func-
tions are closely interrelated and that the change
of any function could result in the modulation of
other functions. These defensive functions are
interrelated by co-localization, biochemical link-
age or through common regulatory mechanisms.
The epidermal permeability barrier and its anti-
microbial barrier function
As an antimicrobial barrier against invading
microorganisms, skin acts as a physical barrier
and produces a number of antimicrobial peptides
and proteins, including human defensins and
cathelicidins. These antimicrobial peptides (AMPs),
which play a major role in the host's innate de-
fenses, are generally small, cationic polypeptides
and have a capacity to inhibit the growth of
microbes. In addition to the direct antimicrobial
activities against various bacteria, viruses and
fungi, AMPs also activate cellular and adaptive
Fig. 1. The localization of various protective functions in
the stratum corneum. While the corneocytes (bricks) serve
as UV and mechanical barriers as well as playing a
hydrating role in the stratum corneum, the intercellular
lipids perform the functions of antimicrobial barrier, anti-
oxidant barrier and permeability barrier. It should be
noted, however, that regulation of these protective func-
tions are closely related and modulation of one function
can affect other functions.
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immune responses. They also play important roles
as mediators of inflammation with effects on
epithelial and inflammatory cells, influencing cell
proliferation, wound healing, cytokine and che-
mokine production and chemotaxis. While cathe-
licidins and defensins comprise the major families
of AMPs in the skin, other molecules such as pro-
tease inhibitors, chemokines and neuropeptides,
also exhibit antimicrobial activity. In addition to
those molecules, free fatty acids, glucosylcera-
mides and sphingosine, which are major consti-
tuents for SC intercellular lipids, and hydrolytic
products of ceramide also provide an antimi-
crobial barrier in the skin.
While AMPs are generally synthesized in the
upper stratum spinosum (SS) and stratum granu-
losum, the active site for these molecules is the SC
where they are delivered. Recently, it has been
shown that human -defensin 2 (HBD-2) is localβ -
ized in the lamellar bodies (LBs)15 and catheli-
cidin also resides in LBs.16 Since the LB is an
essential micro-organelle for epidermal barrier
formation, it can be postulated that the epidermal
permeability barrier function is closely related to
the antimicrobial function of skin. In several skin
diseases showing disturbed skin barrier function,
such as psoriasis and atopic dermatitis (AD),
abnormal expression of AMPs was reported. For
example, LL-37, hBD-2 and hBD-3 are up regu-
lated in psoriatic skin lesions.17,18 The expression
of LL-37 and hBD-2 is relatively down regulated
in atopic dermatitis lesions compared to psoriatic
skin,
19
which correlates with the high suscepti-
bility of AD skin to bacterial and viral infections.
Recently, we have reported that epidermal ex-
pression of CRAMP, a murine analogue of human
LL-37, is significantly increased after UVB expo-
sure.20 Since phototherapy using UVB is fre-
quently used in severe AD, increases in AMPs can
give a supplemental explanation for the beneficial
effect of UV in AD.
KERATINOCYTE DIFFERENTIATION AND
BARRIER FUNCTION
The formation of corneocytes is considered to
be a result of finely regulated differentiation pro-
cesses. During the terminal differentiation process,
structural change of the keratinocyte is associated
with the sequential formation of differentiation-
marker proteins that are unique to keratinocytes.
Keratins such as K1 and K10, as early marker
proteins of terminal differentiation, are expressed
in the spinous layer. Late differentiation marker
proteins, including involucrin, loricrin and filag-
grin, appear in the granular layer. Complete
degradation of intracellular micro-organelles such
as nucleus and mitochondria and the formation of
rigid CE complete the differentiation process.
Keratinocyte-specific transglutaminase-1 catalyzes
the cross-linking reaction between keratins and
other structural proteins to form the chemically
resistant cornified envelope structures of corneo-
cytes.11
An in vitro cell culture system has been exten-
sively used to identify the crucial factors in-
fluencing keratinocyte differentiation. Through
these intensive studies, it has been shown that the
epidermal differentiation process is regulated by
the concentration of extracellular calcium ions.
Keratinocytes cultured in low calcium concen-
trations (0.04 mM) show an undifferentiated, basal
cell-like phenotype. Raising calcium concentra-
tions up to 0.14 mM in the medium results in a
terminal differentiation process, which is almost
identical to the in vivo process. The early differen-
tiation markers, K1 and K10, are observed within
8-24 hrs, and the late markers, loricrin and filag-
grin, are shown after 24-48 hrs. A difference not
found in vitro is the down-regulation of K14
expression, which takes place in differentiating
keratinocytes in vivo but is constitutively ex-
pressed in cultured keratinocytes. A relationship
between elevated calcium ion concentration and
keratinocyte differentiation is observed both in
vivo and in vitro, where a calcium gradient has
been well documented in human and murine
epidermis. Higher calcium levels occur in the dif-
ferentiated granular and spinous layers as com-
pared to the undifferentiated basal layer. From
these findings, the calcium-sensitive signaling
pathway, involved in the regulation of keratino-
cyte differentiation, was elucidated.
The epidermal calcium gradient, however, not
only regulates the epidermal differentiation pro-
cess, but also regulates the homeostasis of the
epidermal permeability barrier. Several signals
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have been suggested for mediating the homeo-
static responses after skin barrier disruption.
Occlusion of barrier-disrupted skin with water
vapor-impermeable membrane could block the
lipid synthesis responses to barrier disruption,
which also suggests that TEWL is a regulatory
signal in barrier homeostasis. When the barrier
disrupted skin was immediately exposed to iso-
osmolar, hyperosmolar or hypoosmolar external
solutions, however, the barrier recovery responses
were normalized, which suggests that water
movement, itself, might not be considered as a
major signal in barrier homeostasis. The epider-
mal calcium gradient, with its highest level in the
granular layer and its lowest level in the basal
layer, disappears after barrier disruption, and
reappears in parallel with barrier restitution. In a
previous study, it was shown that immersion of
barrier-disrupted skin into a calcium containing
solution significantly delayed barrier recovery.
The central role of calcium ions in the skin barrier
was also demonstrated by manipulating LB secre-
tion by changing the epidermal calcium gradient
without changing TEWL, using iontophoresis or
sonophoresis. These studies suggest that changes
in calcium ion concentration in the stratum granu-
losum (SG) can directly induce the homeostatic
signals for barrier repair, even without a change
in permeability barrier function. The precise
mechanism for the change of intracellular calcium
levels in response to the change of extracellular
calcium, however, is still not clear.
Protein kinase C (PKC) comprises a family of
serine/threonine kinases that play central roles in
the regulation of various cellular processes in
numerous cell types. Currently, eleven PKC iso-
types have been identified, which can be classified
according to their activation factors.21 Human
epidermal keratinocytes express several PKC iso-
forms, such as PKC , , and . Other PKCα δ ε ξ
isoforms (PKC , , ) were found in various otherβ γ μ
keratinocytes. Previous studies suggest a crucial
role for PKC in the regulation of the proliferation
and differentiation of keratinocytes. From these
studies, PKC expression and activity, which was
represented by the change of subcellular localiza-
tion, was seen to alter with calcium induced
keratinocyte differentiation. It was also shown
that inhibition of PKC activity with a selective
PKC inhibitor suppressed the expression of late
differentiation marker proteins, such as involucrin
and filaggrin, and terminal differentiation markers,
such as keratinocyte-specific transglutaminase-1,
in HaCaT keratinocytes. Phorbol 12-myristate 13-
acetate (PMA), an activator of PKC, increased the
expressions of involucrin, filaggrin, and transglu-
taminase-1.22 In addition to its crucial role in
keratinocyte differentiation, PKC might play some
important roles in epidermal permeability barrier
function. Previously, Murata et al. reported that
the activity of serine palmitoyl transferase and
glucosylceramide synthase, both essential for cera-
mide production, was unregulated by a PKC-de-
pendent mechanism in cultured human keratino-
cytes.23 Recently, we have also shown that the
PKC- specific inhibitor, rottlerin, delayed barrierδ
recovery rate by inhibiting the intracellular cal-
cium responses to the loss of the extracellular
calcium gradient.24 Although the precise mecha-
nism of PKC involvement in permeability barrier
homeostasis is still unknown, it seems that some
PKC isozymes are responsible for the regulation
of intracellular calcium concentration during the
permeability barrier recovery process.
THE LAMELLAR BODY AS A MAJOR PLAYER
IN THE FORMATION OF THE PERMEABILITY
BARRIER
The lamellar body (LB), also known as a lamel-
lar granule, a keratinosome, a membrane-coating
granule (MCG), and an Odland body, is a spe-
cialized secretory granule in the epidermal kerati-
nocyte and considered to be essential in epidermal
permeability barrier formation, as well as desqua-
mation.25 LBs are tubular or ovoid-shaped, mem-
brane-bound organelles unique to mammalian
epidermis. The lipid components for SC intercel-
lular lipids, such as glucosylceramide, cholesterol
and phospholipids, are delivered through the LBs
and their respective extracellular processing en-
zymes, including -glucocerebrosidase. Acidicβ
sphingomyelinase and secretory phospholipase
A2 (sPLA2) are also packed in LBs.26 Recently, it
was shown that other materials as well as lipid
precursors, such as antimicrobial peptides,
proteins, protein-degrading enzymes and protease
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inhibitors, are also packed in LBs. Using confocal
laser scanning microscopy and immunoelectron
microscopy, Ishida-Yanamoto et al. showed that
cathepsin D and kallikrein (KLK) 7 are also
packed in LBs. They also showed that each LB has
its own separate molecules.27 More recently, they
also showed that KLK5 and LEKTI (lympho-
epithelial Kazal-type-related inhibitor), a putative
serine protease inhibitor, is also localized in the
LBs.28 The heterogeneous content of the LBs sug-
gests that they are important for not only
epidermal permeability barrier functions, but also
the other defensive functions exerted by the SC.
While the epidermal LBs play a basic and
crucial role in the formation, maintenance and
repair of the epidermal permeability barrier, the
exact mechanism underlying LB formation in the
SG and its extrusion into the SC-SG interface is
not yet fully understood. In a previous report,
Madison and Howard showed that glucosylcera-
mide, a major component of LB and the precursor
of SC ceramides, was produced through the Golgi
apparatus and delivered to the plasma membrane,
which suggested that the Golgi apparatus is the
origin of LB.29 Recently, the role of caveolin pro-
teins in LB formation and secretion has been
suggested. The caveolins are cholesterol-binding
scaffolding proteins that facilitate the assembly of
cholesterol and sphingolipid-enriched membrane
domains, known as caveolae. Previously, Sando et
al. reported morphological evidence of co-localiza-
tion of the caveolin and LBs in the SG, which sug-
gests that caveolins may play a role in LB as-
sembly and function.
30
Caveolae are a subset of
lipid raft domains, which are characterized as
flask-shaped invaginations in the plasma mem-
brane of 50 to 100 nm in diameter and, inter-
estingly, Elias et al. observed a structural simi-
larity between the caveolae and the LB secretion
site.
31
Since the lipid raft provides platforms for
preserving the specificity and efficiency of cell
signal transduction processes,32 it can be postu-
lated that the LB secretory response to barrier
disruption is important not only for replenishing
the lipids to the SC intercorneocyte domains, but
also for creating higher-order signaling complexes
to amplify cellular signaling.33 Recently, numerous
studies using caveolin knockout (KO) mice have
been reported. Interestingly, it was reported that
cavolin-1 KO mice showed no abnormalities in
cutaneous phenotype34 and barrier function re-
covery rate was accelerated after acute perme-
ability barrier disruption,35 which also suggests a
close relationship between the caveolin proteins
and LB formation and its secretion.
CALCIUM IONS AND BARRIER
HOMEOSTASIS
Epidermal permeability barrier homeostasis
The SC intercellular lipid matrix constitutes
about 15% of the dry weight of the SC and the
only continuous phase of the skin barrier. The
unique lamellar, bilayer organization of this lipid
matrix provides the structural basis for the ex-
traordinary lower permeability to water and other
electrolytes through the SC.36 The major lipid
species of the SC are ceramides, fatty acids, and
cholesterol.37 Small amounts of cholesterol esters
and cholesterol sulfates are also present in SC and
both lipids play a critical role in proper structural
organization of SC lipids and, therefore, in normal
barrier function.38 The chemical structures of SC
lipids species are illustrated in Fig. 2.
The majority of SC lipids are derived from LBs
and synthesized in the keratinocyte of the upper
stratum spinosum (SS) and SG. At the SC-SG junc-
tion, phospholipids, sphingolipids, and other pre-
cursor molecules for SC lipids are extruded from
the LB to the SC intercellular spaces. Extracellular
processing of these lipid precursors provides the
SC intercellular lipid matrix. When the epidermal
permeability barrier function is compromised,
several homeostatic responses follow. The first
and most important response is immediate secre-
tion of preformed LBs to the SC-SG interface.
Increased synthesis of LBs in the granulocytes and
continuing secretion to SG-SC interface result in a
restoration of the perturbed barrier function. Syn-
thesis of cholesterol, free fatty acids, and sphingo-
lipids, which are the major constituents for SC
intercellular lamellae, is also increased in the
epidermis to provide the lipid content for nascent
LBs. In addition to the increase of lipid synthesis
in the epidermis, the epidermal expression of
several cytokines and DNA synthesis is also in-
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creased after acute disruption of barrier function,
which could be an additional support for barrier
recovery. In murine epidermis, mRNA expression
of tumor necrosis factor (TNF)- , interleukin (IL)-1α
, IL-1 and granulocyte macrophage-colony-α β
stimulating factor (GM-CSF) are elevated after
barrier disruption (Fig. 3).
For a complete recovery of epidermal permea-
bility barrier function, both the corneocytes of the
SC intercellular lipids need to be replenished into
the barrier-damaged skin site. While a great deal
of studies have been reported on the regulation of
lipid synthesis in the stratum granulosum after
barrier disruption, relatively little is known about
the regulation of keratinocyte differentiation after
barrier disruption and its role in barrier
homeostasis. Peroxisome proliferator- activated
receptor (PPAR) and liver X receptor (LXR)
belong to a subset of the nuclear hormone re-
ceptor superfamily (class II receptors), which need
retinoid X receptor (RXR) as a heterodimerizing
factor for their activation.39 PPAR and LXR are
ligand-activated transcriptional factors that regu-
late the expression of target genes involved in
many cellular functions including cell prolifera-
tion, differentiation and immune/inflammation
responses. Along with the fibrate hypolipidemic
agents, a large number of endogenous fatty acids
and fatty acid metabolites can activate PPAR. Sev
Fig. 3. The epidermal permeability barrier homeostasis. When barrier function is perturbed, immediate secretion of
preformed lamellar bodies occurs, followed by an increased synthesis of lamellar bodies and lipid precursors. Increased
expression of inflammatory cytokines is observed after barrier disruption. Keratinocyte differentiation and proliferation
are also increased after barrier disruption. The epidermal permeability barrier is restored through the above described
homeostatic responses. Iontophoresis, sonophoresis and topical glycolic acid can also induce the down-stream homeostatic
responses without changing the transepidermal water loss.
Fig. 2. The structure of the major components of the
stratum corneum intercellular lipids. Numbers 1 to 8 are
ceramides and represent a thin layer with chromato-
graphic mobility, with ceramide 1 being least polar and
ceramide 8 the most polar. The letters in square brackets
are the structural classifications of the ceramide as sug-
gested by Motta et al. (Biochim Biophys Acta 1993;1182:
145-51).
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eral oxysterols, including cholesterol, can activate
LXR.40 Activation of PPAR and LXR in skin,
induced various cellular responses including the
promotion of keratinocyte differentiation and al-
leviation of epidermal hyperproliferation, as well
as the reduction of epidermal inflammation.41 Re-
cently, it was also shown that topical application
of PPAR or LAX activator on barrier-disrupted
skin improves epidermal permeability barrier
recovery, inducing an increase of epidermal lipid
synthesis and LB secretion.42 Since endogenous
lipids produced in the keratinocyte can activate
PPAR or LXR, and, in turn, regulate lipid metab-
olism of the keratinocyte, these receptors are cur-
rently referred to as 'liposensors' in keratinocytes,
and considered major players connecting lipid
metabolism and keratinocyte differentiation.
Calcium's role in barrier homeostasis
In 1985, Menon et al. reported that an epidermal
calcium gradient with low calcium concentrations
in the basal, proliferating layers, and a progres-
sively higher concentration as one proceeds to the
outer differentiated layers, i.e. the SG.43 Several
years later, it was suggested that this epidermal
calcium gradient plays a crucial role in skin
barrier function.44 Acute barrier disruption with
either acetone treatment or repeated tape strip-
ping induced an immediate, marked decrease of
intracellular calcium concentrations in the SG. The
calcium levels in the SG then progressively nor-
malized in parallel with barrier recovery over 24
hours.45 Recently, Elias et al. reported the relation-
ship of barrier function and the reappearance of
the epidermal calcium gradient after acute barrier
disruption.46 Immediate application of a vapor-
permeable membrane on the barrier-disrupted
skin provided an artificial permeability barrier
and accelerated epidermal calcium gradient for-
mation. While the exposure of barrier-disrupted
skin to a cold environment retarded both the barrier
recovery and calcium gradient formation, vapor-
permeable membrane application with cold expo-
sure resulted in significant calcium gradient for-
mation after three hours, without barrier recovery.
With these results, it can be postulated that barrier
status dominantly regulates the formation of the
epidermal calcium gradient and calcium gradient
formation or maintenance is achieved though
passive, ATP-independent processes.
Many studies exploring the relationship between
permeability barrier homeostasis and epidermal
calcium ions have been reported. Sonophoresis
and iontophoresis are both used for increasing the
delivery of drugs and other bioactive materials
across the SC and were shown to decrease the
calcium concentrations in the upper epidermis.
While the sonophoresis or iontophoresis-treated
skin showed no changes in TEWL, increased
secretion and synthesis of LB were observed in
both skin layers.47-49 Since the secretion of LB from
the SG and consequent accumulation of lamellar
materials at the SC-SG junction is a hallmark for
barrier homeostatic responses after barrier dis-
ruption, these results showed that the regulation
of LB secretion is mediated by calcium ions in the
SG. Recently, it has been reported that several
agonists and antagonists for G-protein-coupled
receptors (GPCRs) expressed in keratinocytes,
such as the - aminoγ butyric acid receptor (GABA),50
the P2X purinergic receptor,51 the NMDA type
glutamate receptor,52 the 2-adrenergic receptorβ 53
and the histamine receptor,54 have accelerating or
delaying effects on barrier recovery after acute
barrier disruption. Since the major signaling
molecules for GPCRs include intracellular calcium
ions, it can be concluded that the change of intra-
cellular calcium ion concentration is a major
signal for permeability barrier homeostasis. In
addition to the GPCR activation-related calcium
modulation, we have also shown that topical
application of calcium chelating agents onto nor-
mal skin induced the barrier homeostatic re-
sponses, including loss of the epidermal calcium
gradient and LB secretion.55 Topical application of
glycolic acid, which does not induce any changes
in TEWL in normal murine skin, significantly
increased LB secretion56,57 and an in vitro study
using cultured keratinocytes suggests that glycolic
acid could lower the calcium ion concentration, at
least in part, through its chelating effects on
cations, such as calcium ions.
pH AND BARRIER HOMEOSTASIS
It is well known that skin surface pH, which
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ranges from pH 4.5 to pH 5.5 in humans, is
slightly acidic compared to the normal phy-
siologic pH.58 SC acidity, or the "acid mantle" is
currently considered to be crucial for establishing
the epidermal permeability barrier, as well as for
producing the epidermal antimicrobial barrier and
controlling SC integrity and cohesion. Various
endogenous and/or exogenous pathways are cur-
rently suggested for acidifying the pH of the SC.
Endogenous factors influencing SC acidification
include the generation of free fatty acids from
phospholipid hydrolysis catalyzed by secretory
phospholipase A2 (sPLA2) and the sodium-proton
antiporter-1, NHE1, which is expressed in the
outer, nucleated layers of the epidermis.59 Exoge-
nous mechanisms include the generation of free
fatty acids by bacterial lipase, free fatty acids
derived from sebum60 and eccrine gland-derived
products, such as lactic acid (Fig. 4).
61
In atopic eczematous lesions, the epidermal
permeability barrier is perturbed and the skin pH
is also significantly elevated.
62
In addition to the
perturbation of lipid metabolism and their mole-
cular organization, increased skin pH also induces
bacterial growth (e.g. Staphylococcus aureus).
Diverse functions for this acid mantle have been
suggested, one of the major ones being antimi-
crobial action. A few studies relating surface pH
and its role in supporting the growth of normal
microflora as well as inhibiting skin pathogen
growth have been previously reported.63 A typical
example where the impaired antimicrobial barrier
is correlated with elevated skin surface pH is
diaper dermatitis. Due to chronic exposure to
urine and feces, diapered, neonatal skin shows a
more neutral pH than uncovered skin.64 In addi-
tion, pathogens that grow at neutral pH worsen
diaper dermatitis,65 resulting in a vicious cycle
where neutral pH-enhanced pathogen growth and
inflammatory cytokine release combine to pro-
duce an inflamed, colonized skin with impaired
antimicrobial barriers.66
Another important function of the acid mantle
is related to the extracellular processing of LB-
derived lipid precursors, which comprise the SC
intercellular lipid domain. Among the various
important enzymes in SC are -glucocerebroβ -
sidase, acid sphingomyelinase and secreted phos-
pholipase A2 (sPLA2). Each of these functions
optimally in an acidic environment and contri-
butes to the generation of the ceramide molecules
and free fatty acids required for epidermal per-
meability barrier homeostasis. Acute disruption of
the permeability barrier results in a slight but
significant increase in skin surface pH. Along with
the barrier recovery, the acid mantle reappears.
Recent reports using super-acid or super-base,
which could modulate skin surface pH without
affecting viable epidermis, also showed that skin
surface pH regulated the epidermal barrier home-
ostasis.67 In addition, maintenance of intact
murine SC to a neutral pH produced significant
abnormalities in SC integrity and cohesiveness.68
Using neonatal hairless mice, Fluhr et al. showed
that topical application of liver X receptor (LXR)
activators accelerated SC acidification, as well as
stimulated keratinocyte differentiation and im-
proved permeability barrier homeostasis.69 Among
the proposed acidification pathways, LXR acti-
vators induced the increase of secretory phos-
pholipase A2 (sPLA2) activity in the SC. The
above described roles of the SC acid mantle in
epidermal permeability barrier function suggest
that both barriers are closely related and mainte-
nance of skin surface pH in the normal acidic
range is crucial for not only the antimicrobial
barrier, but epidermal permeability barrier func-
tion as well.
Fig. 4. The endogenous and exogenous factors affecting
stratum corneum acidification. Exogenous, free fatty acids
are either derived from sweat glands or catalyzed from
sebaceous gland-originated triglycerol by microorganism-
secreted lipases. Endogenous free fatty acids are derived
from phospholipids by phospholipase A2 (PLA2), both of
which are secreted by lamellar bodies at the stratum cor-
neum-stratum granulosum junction. The Na
+
/H
+
antipor-
ter is also involved in maintaining the skin acid mantle.
Skin Barrier Functions: an Update
Yonsei Med J Vol. 47, No. 3, 2006
Skin surface pH also affects the desquamation
processes. A lot of protein degrading enzymes
and proteases exist in the SC and each protease
has its optimal pH, respectively (Fig. 5).70,71 Since
each protease has its own substrate in the corneo-
desmosome components, changes in pH induce
abnormal desquamation and results in a scaly
skin. A typical example of abnormal desquama-
tion induced by alkaline pH is soap-induced
xerotic skin.72
In addition, skin pH is also related to the activa-
tion of the protease-activated receptor-2 (PAR-2)
in skin. The protease-activated receptor (PAR) is
a seven transmembrane G-protein-coupled recep-
tor, distinguished by a unique mechanism of self-
activation following specific proteolytic cleavage
of its extracellular domains.73 It was reported that
PAR2 agonist peptides significantly delay epider-
mal permeability barrier recovery after acute
barrier disruption in murine skin,74 possibly due
to the increase of intracellular calcium concentra-
tion in epidermal keratinocytes. Previous studies
also showed that serine protease activity was in-
creased in atopic dermatitis, and it has been pos-
tulated that increased PAR-2 activity could be a
pathophysiologic factor for atopic dermatitis.75
Recently, we have reported the effects of PAR-2
activators on epidermal barrier functions, as well
as on epidermal calcium gradients. Cockroach
allergens and house dust mite allergens, both
known to be associated with the development of
asthma and atopic dermatitis, could activate PAR-
2 and thereby induce various cellular responses.76,
77 Topically applied PAR-2 activators delayed the
barrier recovery, which might be due to the
change of intracellular calcium concentration.
Since the protease in cockroach and house dust
mite allergens have their highest activity at neu-
tral pH, maintaining an acidic pH after barrier
disruption significantly prevented the inhibitory
effects of both allergens on epidermal permea-
bility barrier recovery.
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BARRIER DYSFUNCTIONS IN SKIN DISEASES
Currently, several skin diseases are known to
show a defect in epidermal permeability barrier
function as a major or minor pathophysiologic
factor. While the most representative ones include
atopic dermatitis and psoriasis, other skin diseases
caused by genetic defects in lipid metabolism are
also accompanied by barrier defects. Recessive
X-linked lamellar ichthyosis (RXLI) is one such
disease. It is caused by a deficiency in the enzyme
steroid sulfatase and leads to an accumulation of
cholesterol sulfate and a reduction of cholesterol.
The abnormality of cholesterol sulfate/cholesterol
Fig. 5. The activation of corneodesmosome degrading protease in the stratum corneum. SCCE/KLK7 and KLK17 are
activated by the tryptic cleavage of a short amino-terminal domain of Pro-SCCE and pro-KLK14 by SCTE/KLK5.
Pro-SCTE/KLK7 is autoactivated to yield active SCTE/KLK5. The cathepsin activator is unknown. The proteolytic
activities of each protease are regulated by their chemical and biochemical environment, including the pH and the
protease inhibitors in the stratum corneum. SCTE, stratum corneum tryptic enzyme; SCCE, stratum corneum
chymotryptic enzyme; LEKTI, lymphepithelial Kazal-type 5 serine protease inhibitor; SKALP, skin-derived-antileuko-
protease; ALP, antileukoproteinase; SLPI, secretory leukocyte protease inhibitor.
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balance results in an altered lipid organization
and consequent abnormality in the structural or-
ganization of the intercorneocyte lipid lamellae.79
Cholesterol sulfate is also known to affect other
biological processes such as protease activity in
the SC, which results in abnormal desquamation
in the RXLI.13 In addition to the inhibitory effects
on protease in the SC, cholesterol sulfate also acts
as an activating factor for the eta isoform of pro-
tein kinase C (PKC eta). PKC eta is a subtype of
novel PKC and, in the keratinocyte, is closely as-
sociated with cell cycle arrest and differentiation.80
It can, therefore, be postulated that cholesterol sul-
fate is also related to the differentiation of epider-
mal keratinocytes. Other genetic skin diseases,
including Netherton syndrome,81 characterized by
defects in proteolysis, and type 2 Gaucher disease,
exhibiting defects in -glucocerebrosidase, involveβ
skin barrier abnormalities as a pathologic out-
comes.
While various pathogenic factors are suggested
for AD, impaired barrier function is currently
considered an important one. Atopic dry skin
displays impaired barrier function, indicated by
an increased transepidermal water loss and
lowered water-binding capacities. Significant de-
creases in SC ceramide,82 especially in ceramide 1
(CER EOS) levels is reported in AD skin.83
Bouwstra et al. suggested that the ceramide 1 in
SC intercellular lipids plays a dominant role in the
formation of proper molecular organization.84 In
addition, Pilgram et al. reported that the abnormal
lipid organization in the SC of AD patients re-
sulted from the decrease of ceramide 1 and sug-
gested that the impaired barrier function of AD
skin was, at least in part, due to this structural
change.85 Recently, we have reported a structural
property of a physiologic lipid mixture containing
a pseudoceramide, which showed a close simi-
larity to that of SC intercellular lipids.
36
Since the
structural property of lipids can affect the epider-
mal permeability barrier function, it might be
beneficial to barrier function to use the physio-
logic lipid mixture on the barrier-disrupted skin.
The decrease of ceramides in AD patients is
linked to an increased expression of sphingomye-
lin deacylase, which converts the sphingomyelin
to free fatty acids and sphingosylphosphorylcho-
line.86 In normal skin, epidermal sphingomyelin is
catalyzed by sphingomyelinase to produce cera-
mide, but in AD skin, extraordinary sphigomyelin
deacylase activity is presented. Recently, the ex-
istence of another novel enzyme, termed as gluco-
sylceramide deacylase, has been reported in AD
skin lesions. In normal skin, glucosylceramide,
secreted into the SC through LBs, is catalyzed by
-glucocerebrosidase to produce ceramide. In ADβ
skin, however, glucosylceramide is catalyzed by
this novel enzyme to produce glucosylsphin-
gosine.87 With this enzymatic abnormality, cera-
mide level is down regulated in AD skin, and
permeability barrier function is incompetent (Fig.
6). Altered ceramide metabolism in AD skin also
induces a decrease in sphingosine, which is pro-
duced from ceramide by ceramidase in the SC.
Since sphingosine is known to have potent anti-
microbial activities on Staphylococcus aureus at
physiologic levels, down regulation of sphingo-
sine is one of the reasons for the vulnerability of
AD patients to S. aureus colonization.88
In addition to the abnormalities in lipid pro-
cessing metabolism, genomic defects can also
affect the barrier abnormalities in AD. Recently, it
was reported that there is a lack of differentia-
tion-specific gene expression in the keratinocytes
in AD skin lesions. Using a large-scale DNA
microarray Sugiura et al. showed a significant
decrease of mRNA expression of filaggrin and
loricrin in AD skin.89 More recently, loss-of-func-
tion mutations for keratinocyte-differentiation
related-genes encoding filaggrin are observed in
AD patients and suggested as an important risk
factor in AD.
90
As seen in another recent report
showing filaggrin gene mutations in several
families of ichthyosis vulgaris,91 defects in ade-
quate filaggrin formation in terminal differentia-
tion of epidermal keratinocytes results in abnor-
mal keratinization of skin. Filaggrins are crucial
proteins for terminal differentiation of the epi-
dermal keratinocytes, which form a skin barrier
with the SC intercellular lipids. In addition, pyr-
rolidone carboxylic acid (PCA), as a major com-
ponent of the natural moisturizing factors (NMF)
in skin, is primarily produced from filaggrin
proteins in the SC and plays a vital role in main-
taining the hydration of the SC. It was also
previously reported that filaggrin mutation is
associated with the dry skin phenotype, which is
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characterized by a decrease of the NMF com-
ponents in skin.92 Mutations of filaggrin genes
result in abnormal corneocyte structure and im-
paired barrier function, leading to skin that is
more vulnerable to the penetration of exogenous
allergens than normal skin. Along with the
abnormalities in lipid metabolisms, these findings
suggest that both the bricks and the mortar have
defects in AD skin, and consequent impairment of
epidermal barrier function is an important
pathophysiologic factor for AD.93
Another important skin disease with impaired
barrier function is psoriasis. In this condition,
TEWL are significantly increased, according to
the severity of the lesions.94 Alterations in cera-
mide content and abnormal lipid structures are
also reported in psoriasis.95,96 These changes in-
clude an increase in ceramide with non-hydroxyl
fatty acids and sphingosine (CerNS), ceramide
with 6-hydroxy-4-shingenine and omega-hydroxy
fatty acid ester linked to linoleic acid (CerEOH)
and decreases in ceramide with alpha-hydroxy
fatty acids and sphingosine (CerAS). In addition,
altered cholesterol and fatty acid levels are also
observed in psoriatic lesions. This abnormality in
lipid composition and components results in not
only the alterations in epidermal permeability
barrier function, but also alterations in corneo-
cyte adhesion and desquamation. The cornified
lipid envelope (CLE) structure and its compo-
nents are also changed in psoriasis. While it
needs to be clarified whether the abnormal per-
meability barrier is primary pathophysiologic
factors for these skin diseases or not, many
studies have now shown that improvements in
barrier function resulted in significant ameliora-
tion of disease severity.
CONCLUSIONS
Epidermal permeability barrier function has the
crucial role of maintaining skin homeostasis and
the perturbation of barrier function has significant
effects on overall skin quality. Recently, many
studies have suggested that the defects in per-
meability barrier function are not secondary con-
sequences, but critical factors for various skin
diseases. Therefore, understanding the molecular
basis of barrier function and its homeostatic
responses can provide not only a more rational
therapy of barrier-disrupted skin diseases, but
also improve the specificity and efficacy of treat-
ments for human skin with abnormal SC structure
and function.
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